Cat.#: ACPP-1288
| Despition | C9orf72 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1483 | Human ENO2 Protein (AC1483) | 5 µg | inquiry |
| ACPP-1159 | Recombinant Mouse SIRP alpha Protein (6×His Tag) (AC1159) | 50 µg | inquiry |
| ACPP-1448 | Human I TAC Protein, His (AC1448) | 5 µg | inquiry |
| ACPP-1143 | Recombinant Human Adenosine Receptor A2a Protein (Fc Tag) (AC1143) | 50 µg | inquiry |
| ACPP-1703 | Human PITPNA Protein (AC1703) | 5 µg | inquiry |
| ACPP-1119 | CD56 Blocking Peptide (AC1119) | 250 µg | inquiry |
| ACPP-1444 | Human VAMP2 Protein (AC1444) | 5 µg | inquiry |
| ACPP-1523 | RPE65 Blocking Peptide (AC1523) | 250 µg | inquiry |
| ACPP-1799 | Human SNAP23 Protein (AC1799) | 5 µg | inquiry |
| ACPP-1071 | Visfatin Blocking Peptide (AC1071) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.